Literature DB >> 1621725

Use of prescription-refill records to assess patient compliance.

R A Hamilton1, L L Briceland.   

Abstract

Prescription-refill records were used to assess patient compliance, to evaluate factors previously associated with compliance, and to determine the association between selected drugs and compliance. Records were selected from a computerized database containing prescription-coverage claims, based on the following criteria: (1) the prescriptions were refilled during 1987-1989 and within two times the days' supply after the dispensing date, (2) they involved any of 12 drugs selected for study, (3) they required one to four doses per day, and (4) at least 20 records with the same regimen were available. Compliance was defined as refill within 0.2 times the days' supply after the refill-due date, and it was assessed by calculating the compliance rate and the compliance index (which describes the relationship between the refill-due date and the actual refill date). Data from 19,118 prescription-refill records were analyzed. The compliance index improved slightly as the number of concurrent medications increased, worsened as the number of doses per day increased, and improved as the immediacy of the risk of noncompliance increased. Different medications and indications were associated with different degrees of compliance. Medication compliance generally improves as the number of daily doses decreases, may improve slightly as the number of concurrent medications increases, and varies with the particular drug and indication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621725

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  15 in total

1.  The value of industry-sponsored studies of initial antihypertensive therapies.

Authors:  J J Caro; K Payne
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

2.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

3.  Improving Medication Adherence in a Regional Healthcare Information Exchange using a Scalable, Claims-Driven, and Service-Oriented Approach.

Authors:  Guilherme Del Fiol; Kensaku Kawamoto; Nancy M Allen Lapointe; Eric L Eisenstein; Kevin J Anstrom; Laura L Wood; David F Lobach
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

4.  Associations between adverse social position and bone mineral density in women aged 50 years or older: data from the Manitoba Bone Density Program.

Authors:  S L Brennan; W D Leslie; L M Lix
Journal:  Osteoporos Int       Date:  2013-02-22       Impact factor: 4.507

5.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

6.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

7.  FRAX provides robust fracture prediction regardless of socioeconomic status.

Authors:  S L Brennan; W D Leslie; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2013-11-05       Impact factor: 4.507

8.  Fracture prediction from repeat BMD measurements in clinical practice.

Authors:  W D Leslie; S L Brennan-Olsen; S N Morin; L M Lix
Journal:  Osteoporos Int       Date:  2015-08-05       Impact factor: 4.507

9.  Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Authors:  Menna Alene; Michael D Wiese; Mulugeta T Angamo; Beata V Bajorek; Elias A Yesuf; Nasir Tajure Wabe
Journal:  BMC Clin Pharmacol       Date:  2012-06-18

10.  Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial.

Authors:  Daniel D L Bernal; Leanne Stafford; Luke R E Bereznicki; Ronald L Castelino; Patricia M Davidson; Gregory M Peterson
Journal:  Trials       Date:  2012-04-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.